ストックスクリーナーアプリを入手
4.56
4.20%
-0.20
アフターアワーズ：
4.67
0.11
+2.41%
前日終値:
$4.76
開ける：
$4.74
24時間の取引高:
203.79K
Relative Volume:
0.07
時価総額：
$56.11M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-2.77%
1か月 パフォーマンス:
+14.29%
6か月 パフォーマンス:
+165.12%
1年 パフォーマンス:
+103.57%
1日の値動き範囲:
$4.36
$4.77
1週間の範囲:
$4.30
$4.82
52週間の値動き範囲:
$1.345
$6.3699
Q 32 Bio Inc Stock (QTTB) Company Profile
Compare QTTB vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
4.56 | 58.57M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.83 | 121.97B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.67 | 81.49B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
766.92 | 47.74B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
332.92 | 43.93B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
316.99 | 35.67B | 4.98B | 69.60M | 525.67M | 0.5198 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-11 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-12-11 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
| 2024-10-24 | 開始されました | Raymond James | Strong Buy |
| 2024-09-11 | 開始されました | Wells Fargo | Overweight |
| 2024-06-17 | 開始されました | Guggenheim | Buy |
| 2024-05-21 | 開始されました | Leerink Partners | Outperform |
| 2024-04-11 | 開始されました | Oppenheimer | Outperform |
| 2024-04-02 | 開始されました | Piper Sandler | Overweight |
| 2023-07-28 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | 繰り返されました | BTIG Research | Neutral |
| 2022-02-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-02-22 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | 開始されました | Stifel | Hold |
| 2020-12-14 | 再開されました | H.C. Wainwright | Buy |
| 2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-25 | 再開されました | BofA/Merrill | Buy |
| 2020-05-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-03-16 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-02-24 | 開始されました | Chardan Capital Markets | Buy |
| 2019-11-01 | 開始されました | Oppenheimer | Perform |
| 2019-09-10 | 開始されました | Robert W. Baird | Outperform |
| 2019-04-12 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Q 32 Bio Inc (QTTB) 最新ニュース
HC Wainwright & Co. Initiates Coverage of Q32 Bio (QTTB) with Buy Recommendation - Nasdaq
H.C. Wainwright initiates Q32 Bio stock coverage with buy rating - Investing.com
Q32 Bio Inc. $QTTB Shares Sold by Monaco Asset Management SAM - MarketBeat
Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight (2026-02-19) - Seeking Alpha
Biotech Q32 Bio joins Oppenheimer health conference Feb. 25 webcast - Stock Titan
Q32 Bio Announces $10.5 Million Registered Direct Offering - TipRanks
According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), biotechnology company Q32 Bio Inc has officially signed an agreement to issue and sell approximately 1.7 million shares of common stock. - Bitget
Q32 Bio Launches $10.5 Million Registered Direct Offering - marketscreener.com
Q32 Bio announces $10.5 million registered direct offering - marketscreener.com
Can Q32 Bio Inc. navigate macro headwindsJuly 2025 Big Picture & Safe Swing Trade Setups - mfd.ru
Is Q32 Bio Inc. stock supported by strong cash flows2025 Sector Review & Daily Growth Stock Tips - mfd.ru
What is the fair value of Q32 Bio Inc. stock nowRate Cut & Community Trade Idea Sharing Platform - mfd.ru
Growth Value: Will Q32 Bio Inc stock benefit from M A2025 Top Decliners & Growth Focused Entry Point Reports - baoquankhu1.vn
Pullback Watch: Will Q32 Bio Inc benefit from geopolitical trendsTrade Risk Summary & Accurate Buy Signal Alerts - baoquankhu1.vn
Market Review: Will Q32 Bio Inc benefit from geopolitical trendsWeekly Stock Recap & Community Shared Stock Ideas - baoquankhu1.vn
Dow Update: Will Q32 Bio Inc benefit from geopolitical trendsEarnings Risk Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Aug PreEarnings: Is Q32 Bio Inc exposed to currency risksJuly 2025 Trade Ideas & Precise Buy Zone Tips - baoquankhu1.vn
Aug Levels: Can SHLS beat the S P 500Weekly Trading Summary & Fast Momentum Entry Tips - baoquankhu1.vn
How Q32 Bio Inc. stock benefits from global expansionRecession Risk & Reliable Volume Spike Trade Alerts - ulpravda.ru
Is Q32 Bio Inc. stock attractive after correctionJuly 2025 Trends & Weekly Consistent Profit Watchlists - Улправда
Will Q32 Bio Inc. stock deliver better than expected guidanceJuly 2025 Reactions & Entry and Exit Point Strategies - Улправда
Can Q32 Bio Inc. stock attract ESG capital inflowsQuarterly Market Review & Detailed Earnings Play Strategies - Улправда
Will Q32 Bio Inc. stock maintain momentum in 2025Market Trend Review & AI Based Trade Execution Alerts - Улправда
Q32 Bio Shares Soar After Offloading Phase 2 Complement Drug to Akebia - MSN
Aug Gainers: How Q32 Bio Inc. stock benefits from global expansion2025 Top Decliners & AI Driven Stock Movement Reports - Улправда
Portfolio Recap: Will Q32 Bio Inc. stock maintain momentum in 2025July 2025 Drop Watch & Breakout Confirmation Alerts - Улправда
Why retail investors pile into Q32 Bio Inc. stock2026 world cup usa national team round of 16 midfield engines high defensive line group prediction breakdown - Улправда
Form 8K Q32 Bio Inc For: 19 December - Investing.com
Fundamentals Check: Will Q32 Bio Inc stock gain from lower inflationWatch List & Consistent Profit Trading Strategies - moha.gov.vn
Q32 Bio Retains Mark Iwicki as Board Chair - The Globe and Mail
Q32 Bio director Mark Iwicki withdraws resignation and will remain board chair - Investing.com
How Q32 Bio Inc. stock trades before earningsWeekly Trading Summary & Real-Time Buy Signal Alerts - DonanımHaber
Why Q32 Bio Inc. stock remains on watchlistsJuly 2025 EndofMonth & Reliable Price Breakout Signals - DonanımHaber
Will Q32 Bio Inc. stock gain from lower inflationNew Guidance & Safe Entry Momentum Stock Tips - DonanımHaber
Can Q32 Bio Inc. stock deliver strong Q4 earningsMarket Trend Review & Breakout Confirmation Alerts - DonanımHaber
Q32 Bio Inc.(NasdaqCM: QTTB) dropped from NASDAQ Biotechnology Index - marketscreener.com
Oppenheimer maintains Outperform rating on Q32 Bio stock at $20 target - Investing.com
Will Q32 Bio Inc stock gain from lower inflationWeekly Gains Summary & Fast Moving Market Watchlists - moha.gov.vn
Aug Technicals: Can Q32 Bio Inc stock attract ESG capital inflowsQuarterly Profit Review & Verified Momentum Stock Ideas - Bộ Nội Vụ
Q32 Bio Insiders Benefit From Selling Stock At US$2.86 - simplywall.st
Stock Market Recap: Why millennials buy Spire Inc LGR stockInsider Buying & Safe Swing Trade Setups - BỘ NỘI VỤ
Q32 Bio Inc. (QTTB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Q32 Bio Inc. stock a defensive play in 2025Quarterly Profit Report & Accurate Technical Buy Alerts - Newser
Q32 Bio CEO Morrison sells $77870 in stock By Investing.com - Investing.com UK
Is Q32 Bio Inc. stock recession proofWeekly Profit Report & Technical Analysis for Trade Confirmation - Newser
Lee Kalowski, Q32 Bio CFO, sells $31k in shares By Investing.com - Investing.com South Africa
Insider Sell: Lee Kalowski Sells Shares of Q32 Bio Inc (QTTB) - GuruFocus
Q 32 Bio Inc (QTTB) 財務データ
Q 32 Bio Inc (QTTB) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Q 32 Bio Inc (QTTB) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Morrison Jodie Pope | CEO |
Feb 25 '26 |
Sale |
4.51 |
9,896 |
44,675 |
89,104 |
| Violette Shelia M. | Chief Scientific Officer |
Feb 25 '26 |
Sale |
4.51 |
2,815 |
12,708 |
55,569 |
| Morrison Jodie Pope | CEO |
Dec 02 '25 |
Sale |
3.46 |
22,506 |
77,871 |
99,000 |
| Kalowski Lee | CFO and President |
Dec 02 '25 |
Sale |
3.46 |
9,072 |
31,395 |
39,938 |
1.18%
0.45%
大文字化:
|
ボリューム (24 時間):